D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 55 Citations 9,344 154 World Ranking 1568 National Ranking 8

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Genetics

Paul D. van Helden focuses on Tuberculosis, Mycobacterium tuberculosis, Immunology, Genetics and Drug resistance. His Tuberculosis research is multidisciplinary, incorporating perspectives in Virology, Internal medicine, Disease, Gene and Pharmacology. His Mycobacterium tuberculosis study incorporates themes from Restriction fragment length polymorphism, Genotype, Incidence and Microbiology.

The study incorporates disciplines such as Tuberculin, Multiplex and Genetic predisposition in addition to Immunology. His research in Genetics intersects with topics in Cape and Genetic admixture. His study in the field of Extensively drug-resistant tuberculosis is also linked to topics like Resistance mutation.

His most cited work include:

  • Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology (899 citations)
  • Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions (335 citations)
  • Rate of Reinfection Tuberculosis after Successful Treatment Is Higher than Rate of New Tuberculosis (328 citations)

What are the main themes of his work throughout his whole career to date?

Paul D. van Helden spends much of his time researching Tuberculosis, Mycobacterium tuberculosis, Mycobacterium bovis, Immunology and Genetics. Paul D. van Helden combines subjects such as Transmission, Virology, Internal medicine, Disease and Drug resistance with his study of Tuberculosis. The various areas that Paul D. van Helden examines in his Drug resistance study include Drug and Intensive care medicine.

His Mycobacterium tuberculosis study integrates concerns from other disciplines, such as Restriction fragment length polymorphism, Genotype, Sputum and Microbiology. Paul D. van Helden focuses mostly in the field of Mycobacterium bovis, narrowing it down to topics relating to Wildlife and, in certain cases, Livestock. His biological study spans a wide range of topics, including Incidence and Haplotype.

He most often published in these fields:

  • Tuberculosis (51.33%)
  • Mycobacterium tuberculosis (36.33%)
  • Mycobacterium bovis (20.33%)

What were the highlights of his more recent work (between 2018-2021)?

  • Mycobacterium bovis (20.33%)
  • Tuberculosis (51.33%)
  • Virology (18.33%)

In recent papers he was focusing on the following fields of study:

His main research concerns Mycobacterium bovis, Tuberculosis, Virology, Bovine tuberculosis and Mycobacterium tuberculosis. His Mycobacterium bovis research includes themes of Zoology, Interferon gamma, Immune system, Microbiology and Interferon gamma release assay. He has researched Tuberculosis in several fields, including Disease, Public health and Environmental health.

His work carried out in the field of Virology brings together such families of science as Ceratotherium simum, Rhinoceros and Whole genome sequencing. His work investigates the relationship between Bovine tuberculosis and topics such as National park that intersect with problems in Captive elephants and Infection prevalence. His study in Mycobacterium tuberculosis is interdisciplinary in nature, drawing from both Incidence, Intensive care medicine, Incubation period, Recent transmission and Pediatrics.

Between 2018 and 2021, his most popular works were:

  • Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study (14 citations)
  • Fatal Tuberculosis in a Free-Ranging African Elephant and One Health Implications of Human Pathogens in Wildlife. (13 citations)
  • Evolution of Rifampicin Treatment for Tuberculosis (11 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Enzyme

The scientist’s investigation covers issues in Mycobacterium bovis, Tuberculosis, Interferon gamma, Virology and Interferon gamma release assay. His work deals with themes such as Transmission, Disease cluster, Infection prevalence and Immune system, which intersect with Mycobacterium bovis. The Tuberculosis study combines topics in areas such as Internal medicine and Cohort.

His Interferon gamma study combines topics from a wide range of disciplines, such as Biomarker, Whole blood and Interferon. Paul D. van Helden usually deals with Virology and limits it to topics linked to Serology and Phacochoerus, Tuberculin, Panthera and Free ranging. The study incorporates disciplines such as Pharmacokinetics, Wildlife, One Health, Public health and African elephant in addition to Mycobacterium tuberculosis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology

Karine Brudey;Jeffrey R Driscoll;Leen Rigouts;Wolfgang M Prodinger.
BMC Microbiology (2006)

1261 Citations

Rate of Reinfection Tuberculosis after Successful Treatment Is Higher than Rate of New Tuberculosis

Suzanne Verver;Robin M. Warren;Nulda Beyers;Madalene Richardson.
American Journal of Respiratory and Critical Care Medicine (2005)

487 Citations

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley.
The Lancet Respiratory Medicine (2017)

432 Citations

Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions

Nicolaas C Gey van Pittius;Samantha L Sampson;Hyeyoung Lee;Yeun Kim.
BMC Evolutionary Biology (2006)

421 Citations

Genetic susceptibility to tuberculosis in Africans: A genome-wide scan

Richard Bellamy;Nulda Beyers;Keith P. W. J. McAdam;Cyril Ruwende.
Proceedings of the National Academy of Sciences of the United States of America (2000)

404 Citations

Mycobacterium bovis at the animal-human interface: a problem, or not?

Anita Luise Michel;Borna Müller;Paul David van Helden.
Veterinary Microbiology (2010)

380 Citations

Patients with active tuberculosis often have different strains in the same sputum specimen.

Robin M. Warren;Thomas C. Victor;Elizabeth M. Streicher;Madalene Richardson.
American Journal of Respiratory and Critical Care Medicine (2004)

379 Citations

Zoonotic Mycobacterium bovis - induced tuberculosis in humans.

Borna Müller;Salome Esther Dürr;Silvia Alonso;Jan Hattendorf.
Emerging Infectious Diseases (2013)

356 Citations

Novel Mycobacterium tuberculosis complex pathogen, M. mungi

Kathleen A. Alexander;Pete N. Laver;Anita Luise Michel;Mark C. Williams.
Emerging Infectious Diseases (2010)

314 Citations

Association between tuberculosis and a polymorphic NFκB binding site in the interferon γ gene

Manda Rossouw;Hendrik J Nel;Graham S Cooke;Paul D van Helden.
The Lancet (2003)

295 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Paul D. van Helden

Sebastien Gagneux

Sebastien Gagneux

University of Basel

Publications: 166

Nalin Rastogi

Nalin Rastogi

Institut Pasteur

Publications: 124

Robin M. Warren

Robin M. Warren

Stellenbosch University

Publications: 121

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 113

Gerhard Walzl

Gerhard Walzl

Stellenbosch University

Publications: 111

Keertan Dheda

Keertan Dheda

University of Cape Town

Publications: 87

Dick van Soolingen

Dick van Soolingen

National Institute for Public Health and the Environment

Publications: 79

Stefan Niemann

Stefan Niemann

Research Center Borstel - Leibniz-Center for Medicine and Biosciences

Publications: 78

Christophe Sola

Christophe Sola

University of Paris-Saclay

Publications: 72

Tom H. M. Ottenhoff

Tom H. M. Ottenhoff

Leiden University Medical Center

Publications: 65

Laurent Abel

Laurent Abel

Inserm : Institut national de la santé et de la recherche médicale

Publications: 63

Stefan H. E. Kaufmann

Stefan H. E. Kaufmann

Max Planck Institute for Infection Biology

Publications: 62

Sonia Borrell

Sonia Borrell

Swiss Tropical and Public Health Institute

Publications: 62

Ben J. Marais

Ben J. Marais

Children's Hospital at Westmead

Publications: 60

P. D. van Helden

P. D. van Helden

Stellenbosch University

Publications: 58

Roland Brosch

Roland Brosch

Institut Pasteur

Publications: 57

Something went wrong. Please try again later.